Patent ID: 11857598
Assignee: UNIVERSITY OF SOUTH FLORIDA
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 7:
8. The polyribonucleotide of claim 1, wherein the miRNA-126 target has a sequence that is complementary to a sequence that is 90-100% identical to a portion of SEQ ID NO: 10 and the portion is 5 or more consecutive nucleotides,
wherein the miRNA-145 target has a sequence that is complementary to a sequence that is 90-100% identical to a portion of SEQ ID NO: 11 and the portion is 5 or more consecutive nucleotides,
wherein the miRNA-143 target has a sequence that is complementary to a sequence that is 90-100% identical to a portion of SEQ ID NO: 12 and the portion is 5 or more consecutive nucleotides,
wherein the miRNA-122 target has a sequence that is complementary to a sequence that is 90-100% identical to a portion of SEQ ID NO: 13 and the portion is 5 or more consecutive nucleotides, and
wherein the miRNA-208 target has a sequence that is complementary to a sequence that is 90-100% identical to a portion of SEQ ID NO: 15 and the portion is 5 or more consecutive nucleotides.